ReviewThe Urologic clinics of North America2014
Emerging PSA-based tests to improve screening.
Review in The Urologic clinics of North America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 28 citations in OpenAlex.
- Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.Cancer prevention research (Philadelphia, Pa.) · 2015Trial
- Article
- miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1.Cancer cell international · 2020Article
- Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.BJU international · 2017Article
- Novel biomarkers for the detection of prostate cancer.Journal of clinical urology · 2016Article
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.European urology · 2016Article
- VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.Urology · 2016Article
- Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.Cancer investigation · 2016Article
- Quantifying Gleason scores with photoacoustic spectral analysis: feasibility study with human tissues.Biomedical optics express · 2015Article
- Serum markers in prostate cancer detection.Current opinion in urology · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
This article updates advances in prostate cancer screening based on prostate-specific antigen, its derivatives, and human kallikrein markers. Many men are diagnosed with indolent disease not requiring treatment. Although there is evidence of a survival benefit from screening, the numbers needed to screen and treat remain high. There is risk of exposing men to the side effects of treatment for nonthreatening disease. A screening test is needed with sufficiently good performance characteristics to detect disease at an early stage so treatment may be offered with curative intent, while reducing the number of negative or unnecessary biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.